P. Goepfert

发表

Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry

D. Price, R. Koup, M. Betts, 2006, Nature Medicine.

Characterization of the R572T Point Mutant of a Putative Cleavage Site in Human Foamy Virus Env

M. Mulligan, P. Goepfert, A. Bansal, 2000, Journal of Virology.

Foamy Virus Envelope Glycoprotein Is Sufficient for Particle Budding and Release

M. Mulligan, P. Goepfert, D. Lindemann, 2003, Journal of Virology.

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Hui Li, Tanmoy Bhattacharya, Xiping Wei, 2008, Proceedings of the National Academy of Sciences.

Modeling sequence evolution in acute HIV-1 infection.

Tanmoy Bhattacharya, Michael S Saag, Brian Gaschen, 2009, Journal of theoretical biology.

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Mario Roederer, Martha C Nason, Mark Connors, 2006, Blood.

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.

Guido Ferrari, Sharon Frey, M Juliana McElrath, 2007, Vaccine.

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Xiping Wei, Feng Gao, John R. Mascola, 2005, Journal of Virology.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection

Jörn E. Schmitz, Joseph J. Eron, Barton F. Haynes, 2009, PLoS medicine.

Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection

P. Goepfert, C. Elson, E. Helton, 2017, PLoS pathogens.

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

T. Kepler, X. Chen, M. Egholm, 2011, The Journal of experimental medicine.

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

I. Frank, P. Goepfert, E. Overton, 2016, Open forum infectious diseases.

I. Frank, P. Goepfert, E. Overton, 2015, Open forum infectious diseases.

Cutting Edge: Emergence of CD127high Functionally Competent Memory T Cells Is Compromised by High Viral Loads and Inadequate T Cell Help1

P. Goepfert, David A Hildeman, L. Shang, 2005, The Journal of Immunology.

Cumulative Impact of Host and Viral Factors on HIV-1 Viral-Load Control during Early Infection

P. Goepfert, S. Allen, E. Hunter, 2012, Journal of Virology.

Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts

A. Westfall, P. Goepfert, A. Bansal, 2015, AIDS.

Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome

J. Carlson, P. Goepfert, A. Bansal, 2015, Journal of acquired immune deficiency syndromes.

Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations.

E. Karita, P. Goepfert, S. Allen, 2017, Human immunology.

Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.

O. Kutsch, P. Goepfert, A. Bansal, 2020, The Journal of clinical investigation.

Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial

D. Montefiori, M. McElrath, L. Qin, 2011, PloS one.

Mechanistic inferences from clinical reports of SARS-CoV-2

P. Goepfert, Meagan M. Jenkins, T. McCaw, 2020, Infectious diseases.

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

S. Buchbinder, J. Thakar, P. Goepfert, 2020, Scientific Reports.

Impact of Pre-adapted HIV Transmission

Charles E. DeZiel, Todd M. Allen, D. Heckerman, 2016, Nature Medicine.

Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals

J. Novak, P. Goepfert, Xueling Wu, 2005, AIDS.

I. Frank, P. Goepfert, E. Overton, 2015, Open forum infectious diseases.

Cell Population in Humans T Cells : An Extralymphoid Effector Memory + Breast Milk-Derived Antigen-Specific CD 8 Aldrovandi

G. Aldrovandi, P. Goepfert, W. Decker, 2005 .

Breast Milk-Derived Antigen-Specific CD8+ T Cells: An Extralymphoid Effector Memory Cell Population in Humans1

G. Aldrovandi, P. Goepfert, W. Decker, 2005, The Journal of Immunology.

HIV-Speciﬁc CD8 (cid:1) T Cells from Elite Controllers Are Primed for Survival

P. Goepfert, A. Bansal, J. Shacka, 2013 .

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.

M. McElrath, P. Goepfert, Yuwei Zhu, 2004, The Journal of infectious diseases.

Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration

P. Goepfert, Shixia Wang, Shan Lu, 2008, Journal of Virology.

HLA-I associated adaptation dampens the CD8 T-cell response in HIV Ad5-vectored vaccine recipients.

A. Fiore-Gartland, P. Goepfert, A. Bansal, 2019, The Journal of infectious diseases.

CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription

D. Heckerman, B. Walker, T. Ndung’u, 2010, The Journal of experimental medicine.

HLA-II-Associated HIV-1 Adaptation Decreases CD4+ T-Cell Responses in HIV-1 Vaccine Recipients

S. Mallal, J. Carlson, P. Goepfert, 2022, Journal of virology.

Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected

A. Fiore-Gartland, P. Goepfert, A. Bansal, 2019, Journal of Virology.

Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection

A. McMichael, P. Borrow, J. Carlson, 2018, Journal of Virology.

KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function

G. Alter, P. Goepfert, R. Kaslow, 2014, PloS one.

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

J. Kublin, N. Frahm, G. Pantaleo, 2019, Science Translational Medicine.

Speci ﬁ city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi ﬁ ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

S. Hammer, B. Moss, S. Buchbinder, 2014 .

Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection

B. Walker, J. Mullins, J. Prado, 2008, Journal of Virology.

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients

David Heckerman, Jianming Tang, Karina Yusim, 2008, The Journal of experimental medicine.

Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis

David Heckerman, Tianwei Yu, Jonathan M. Carlson, 2012, PLoS pathogens.

Selection bias at the heterosexual HIV-1 transmission bottleneck

Jessica Prince, David Heckerman, Jianming Tang, 2013, Science.

CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype

A. Westfall, O. Kutsch, P. Goepfert, 2017, The Journal of Immunology.

Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals.

A. Westfall, G. Ippolito, P. Goepfert, 2020, Vaccine.

Brief Report: Enhanced Allogeneic Cellular Responses to Mismatched HLA-B Antigens Results in More Efficient Killing of HIV Infected Cells

P. Goepfert, E. Hunter, Jianming Tang, 2016, Journal of acquired immune deficiency syndromes.

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

H. Fennema, H. Schuitemaker, J. Stoddard, 2021, The New England journal of medicine.

Some Basic Cellular Immunology Principles Applied to the Pathogenesis of Infectious Diseases

P. Goepfert, R. P. Bucy, 2002 .

Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol

P. Goepfert, S. Allen, E. Hunter, 2020, Journal of Virology.

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2022, PLoS pathogens.

Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2022, bioRxiv.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19

J. Houp, P. Goepfert, E. Levitan, 2022, Transplant international : official journal of the European Society for Organ Transplantation.

Diminished CD103 (αEβ7) Expression on Resident T Cells from the Female Genital Tract of HIV-Positive Women

M. Saag, P. Goepfert, H. Richter, 2017, Pathogens & immunity.

Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

P. Goepfert, D. Strayer, E. Overton, 2014, Vaccine.

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.

D. Montefiori, M. McElrath, P. Goepfert, 2011, Vaccine.

Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women

P. Goepfert, J. Mestecky, Z. Moldoveanu, 2012, The open AIDS journal.

Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure

Michael J. Patton, A. Gaggar, Jeremy D. Zucker, 2021, medRxiv.

SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.

B. Hahn, F. Bibollet-Ruche, P. Goepfert, 2020, medRxiv : the preprint server for health sciences.

Immune Activation Is Associated with CD8 T Cell Interleukin-21 Production in HIV-1-Infected Individuals

P. Goepfert, A. Bansal, I. Sereti, 2014, Journal of Virology.

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

John P. Moore, P. Bieniasz, T. Ketas, 2020, Cell Reports Medicine.

Menstrual Blood as a Potential Source of Endometrial Derived CD3+ T Cells

P. Goepfert, H. Richter, Z. Hel, 2011, PloS one.

Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.

P. Goepfert, K. Neuzil, Wilbur H. Chen, 2022, Vaccine.

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Catharine I Paules, R. Hyzy, M. Proschan, 2022, The Lancet Respiratory Medicine.

A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum

M. Mulligan, P. Goepfert, K. Shaw, 1997, Journal of virology.

Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.

M. Mulligan, P. Goepfert, J. Mestecky, 2004, AIDS research and human retroviruses.

Detection of mucosal antibodies in HIV type 1-infected individuals.

P. Goepfert, H. Staats, P. Wright, 2002, AIDS research and human retroviruses.

Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing

Alan S. Perelson, Hui Li, Tanmoy Bhattacharya, 2012, PLoS pathogens.

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

Feng Gao, Bette Korber, Tongye Shen, 2011, PLoS pathogens.

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

Michael John Smith, E. Walsh, A. Falsey, 2022, medRxiv.

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Lindsay N. Carpp, M. Andrasik, J. Kublin, 2022, Nature Microbiology.

SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia

T. Ketas, B. Hahn, P. Goepfert, 2022, medRxiv.

Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression

Jessica L. Prince, Martin J. Deymier, M. Altfeld, 2015, Proceedings of the National Academy of Sciences.

Human Immunodeficiency Viruses Types 1 and 2

P. Goepfert, E. Erbelding, R. Kaslow, 2014 .

Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection

A. Kamali, E. Karita, P. Goepfert, 2016, Journal of Virology.

An Endoplasmic Reticulum Retrieval Signal Partitions Human Foamy Virus Maturation to Intracytoplasmic Membranes

M. Mulligan, P. Goepfert, A. Bansal, 1999, Journal of Virology.

, to Intracytoplasmic Membranes Partitions Human Foamy Virus Maturation An Endoplasmic Reticulum Retrieval Signal

M. Mulligan, P. Goepfert, A. Bansal, 1999 .

Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma

M. Mulligan, P. Goepfert, A. Bansal, 2002, Journal of Virology.

Safety and Immunogenicity of a High‐Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV‐1‐Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A

M. Hudgens, D. Montefiori, M. Mulligan, 2002, Journal of acquired immune deficiency syndromes.

HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells

D. Wodarz, D. N. Levy, P. Goepfert, 2016, Retrovirology.

Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine

P. Goepfert, W. Chatham, A. Deshpande, 2020, Lupus.

CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection

S. Mallal, J. Carlson, P. Goepfert, 2019, PLoS pathogens.

A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon

M. Mulligan, P. Goepfert, A. Bansal, 2000, Journal of Virology.

The foamy virus envelope glycoproteins.

P. Goepfert, D. Lindemann, 2003, Current topics in microbiology and immunology.

Human Immunodeficiency Virus-Specific CD8+ T Cells in Human Breast Milk

M. Mulligan, G. Aldrovandi, P. Goepfert, 2002, Journal of Virology.

Cross-Reactivity to Mutated Viral Immune Targets Can Influence CD8+ T Cell Functionality: An Alternative Viral Adaptation Strategy

M. John, S. Mallal, L. Barnett, 2021, Frontiers in Immunology.

Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control

F. Pereyra, B. Walker, M. Lederman, 2010, PLoS pathogens.

HLA Amino Acid Residues in HIV-1 Infection 2

Hunter, E. Karita, P. Goepfert, 2017 .

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.

D. Montefiori, M. Mulligan, R. Belshe, 2001, Vaccine.

Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway

P. Goepfert, E. Helton, Z. Hel, 2014, PLoS pathogens.

Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes

J. Carlson, A. Fiore-Gartland, P. Goepfert, 2021, Journal of virology.

Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection

M. Saag, O. Kutsch, P. Goepfert, 2015, Journal of Virology.

TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells

C. Brander, M. Betts, E. Gostick, 2020, Science Immunology.

Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

P. Goepfert, E. Helton, H. Richter, 2013, Endocrinology.

Dimorphic HLA‐B signal peptides differentially influence HLA‐E‐ and natural killer cell‐mediated cytolysis of HIV‐1‐infected target cells

P. Goepfert, R. Kaslow, Jianming Tang, 2013, Clinical and experimental immunology.

The HIV-1 Antisense Protein (ASP) induces CD8 T cell responses during chronic infection

A. Samri, C. Katlama, P. Goepfert, 2015, Retrovirology.

Characterization of T-Cell Responses to Cryptic Epitopes in Recipients of a Noncodon-Optimized HIV-1 Vaccine

P. Goepfert, A. Bansal, A. Sato, 2014, Journal of acquired immune deficiency syndromes.

Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract

P. Goepfert, R. K. Reeves, Kyle Kroll, 2018, AIDS.

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine

H. Schuitemaker, P. Goepfert, D. Heerwegh, 2022, The Journal of infectious diseases.

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.

S. Hammer, H. Liao, T. Hertz, 2016, The Journal of infectious diseases.

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

Tomer Hertz, Julian Wolfson, Holly Janes, 2012, PloS one.

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients

B. Walker, T. Ndung’u, J. Prado, 2009, The Journal of experimental medicine.

Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents

J. Kappes, K. Yusim, P. Goepfert, 2007, AIDS.

Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A

Todd M. Allen, Cynthia A. Derdeyn, Eric Hunter, 2007, Journal of Virology.

Philip J. R. Goulder, Christian Brander, Eric Hunter, 2007, Journal of Virology.

Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients

Jessica L. Prince, A. Perelson, G. Shaw, 2015, PLoS pathogens.

Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes

Todd M. Allen, E. Rosenberg, F. Pereyra, 2006, Journal of Virology.

Host Factor Transcriptional Regulation Contributes to Preferential Expression of HIV Type 1 in IL-4–Producing CD4 T Cells

O. Kutsch, P. Goepfert, R. Cron, 2012, The Journal of Immunology.

Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.

F. Gao, R. Koup, D. Douek, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

H. Schuitemaker, M. Robb, P. Goepfert, 2022, The New England journal of medicine.

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

J. Kublin, D. Montefiori, H. Schuitemaker, 2020, The lancet. HIV.

HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1

D. Cornforth, I. Williams, P. Borrow, 2006, The Journal of Immunology.

Molecular Ecology and Natural History of Simian Foamy Virus Infection in Wild-Living Chimpanzees

N. Gross-Camp, C. Boesch, P. Sharp, 2008, PLoS pathogens.

Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate

M. McElrath, P. Goepfert, C. Gerard, 2022, Clinical & translational immunology.

HIV-1–Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection

J. Carlson, J. Rossjohn, S. Gras, 2016, The Journal of Immunology.

Variants Efficiently Disease Progression Cross-Recognize Epitope Responses Strongly Associated with Delayed T Cell + HIV-1 Epitope-Specific CD 8

D. Cornforth, I. Williams, P. Borrow, 2006 .

CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides

M. Mulligan, G. Aldrovandi, K. Yusim, 2005, AIDS.

Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele1

S. Buchbinder, R. Koup, M. Betts, 2004, The Journal of Immunology.

Expressing the HLA-A*0201 Allele HIV-Uninfected Vaccine Recipients (SL9) Responses among Gag CTL-Positive, Absence of Immunodominant Anti-Gag p17

S. Buchbinder, R. Koup, M. Betts, 2004 .

Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines

M. Mulligan, P. Goepfert, R. Kaslow, 2001, Journal of Virology.

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes

Todd M. Allen, G. Learn, P. Goepfert, 2016, Pathogens & immunity.

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.

S. Kalams, D. Mehrotra, M. Mulligan, 2007, AIDS research and human retroviruses.

Interleukin-2 Production by Polyfunctional HIV-1–Specific CD8 T Cells Is Associated With Enhanced Viral Suppression

P. Goepfert, A. Bansal, S. Heath, 2011, Journal of acquired immune deficiency syndromes.

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

P. Goepfert, B. Kapogiannis, H. Robinson, 2007, Journal of Virology.

Understanding the CD8 T-cell response in natural HIV control

P. Goepfert, Sushma Boppana, 2018, F1000Research.

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4

Hui Li, Charles M. Rice, Wenge Ding, 2015, mBio.

HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses

J. Sidney, J. Carlson, P. Goepfert, 2015, PLoS pathogens.

HLA Class-II Associated HIV Polymorphisms Predict Escape from CD 4 + T Cell Responses

J. Sidney, J. Carlson, P. Goepfert, 2015 .

Applied to the Pathogenesis of Infectious Diseases

P. Goepfert, R. P. Bucy, 2018 .

Interleukin‐2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection

P. Goepfert, R. Reichman, A. Bansal, 2006, Journal of medical virology.

Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.

B. Korber, M. Mulligan, P. Goepfert, 2003, Journal of acquired immune deficiency syndromes.

Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.

J. Shiver, R. Steigbigel, P. Goepfert, 2003, The Journal of infectious diseases.

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

Anurag Sethi, S. Gnanakaran, Persephone Borrow, 2013, PLoS pathogens.

Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses

P. Goepfert, A. Bansal, N. Erdmann, 2021, JCI insight.

Human immunodeficiency virus vaccines.

P. Goepfert, A. Bansal, 2014, Infectious disease clinics of North America.

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline

Michael S Saag, Edward P Acosta, Anju Bansal, 2008, AIDS.

Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients

P. Goepfert, J. Mulenga, S. Allen, 2006, AIDS.

Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic

Gajendra W. Suryavanshi, M. Kamata, P. Goepfert, 2022, iScience.

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans

Christopher D. Scharer, P. Goepfert, T. Randall, 2019, bioRxiv.

Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression

Jessica L. Prince, Tianwei Yu, A. Fiore-Gartland, 2016, The Journal of experimental medicine.

Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]

Alan S. Perelson, Tanmoy Bhattacharya, Eric Delwart, 2012 .

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

W. Blattner, D. Montefiori, S. Kalams, 2011, PloS one.

CD8 T-Cell Proliferative Capacity Is Compromised in Primary HIV-1 Infection

P. Goepfert, A. Bansal, J. Kilby, 2011, Journal of acquired immune deficiency syndromes.

Human antigen-specific memory natural killer cell responses develop against HIV-1 and influenza virus and are dependent on MHC-E restriction

M. Altfeld, P. Goepfert, A. Grundhoff, 2020, bioRxiv.

CD4+ T cells from HIV-1 patients with impaired Th1 effector responses to Mycobacterium tuberculosis exhibit diminished histone and nucleoprotein signatures.

P. Goepfert, L. Seu, J. Mobley, 2017, Clinical immunology.

HIV-Specific CD8+ T Cells from Elite Controllers Are Primed for Survival

P. Goepfert, A. Bansal, J. Shacka, 2013, Journal of Virology.

T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles.

Bette Korber, Anju Bansal, James Tang, 2003, AIDS research and human retroviruses.

Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies

D. Montefiori, M. McElrath, P. Goepfert, 2010, PloS one.

Interleukin-21-Producing HIV-1-Specific CD8 T Cells Are Preferentially Seen in Elite Controllers

P. Goepfert, Wei-Zheng Song, A. Bansal, 2010, Journal of Virology.

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.

H. Liao, B. Haynes, J. Fuchs, 2015, Journal of AIDS & clinical research.

Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?

M. Holick, P. Goepfert, A. Jetten, 2020, American journal of physiology. Endocrinology and metabolism.

SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence

B. Hahn, F. Bibollet-Ruche, P. Goepfert, 2021, PLoS pathogens.

High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.

W. Blattner, J. Fuchs, D. Montefiori, 2005, The Journal of infectious diseases.

HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.

O. Yang, Ayub Ali, P. Goepfert, 2021, The Journal of clinical investigation.

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

W. Blattner, B. Moss, D. Montefiori, 2011, The Journal of infectious diseases.

Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

P. Goepfert, R. Pass, S. Sabbaj, 2011, The Journal of infectious diseases.

Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants

Allan C. deCamp, W. Blattner, S. Hammer, 2014, Clinical and Vaccine Immunology.

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

B. Korber, B. Haynes, D. Montefiori, 2023, The Journal of clinical investigation.

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

S. Hammer, B. Moss, D. Montefiori, 2014, The Journal of infectious diseases.

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2020, bioRxiv.

Circulating SARS-CoV-2+ megakaryocytes are associated with severe viral infection in COVID-19

Michael J. Patton, A. Gaggar, P. Goepfert, 2023, Blood Advances.

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.

D. Mehrotra, M. Mulligan, J. Shiver, 2009, AIDS research and human retroviruses.

AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.

D. Montefiori, S. Buchbinder, M. McElrath, 2021, Vaccine.

Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.

K. Ladell, P. Goepfert, A. Nyakeriga, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.

M. L. Clements-Mann, D. Montefiori, D. Stablein, 2001, The Journal of infectious diseases.

Characterization of Programmed Death-1 Homologue-1 (PD-1H) Expression and Function in Normal and HIV Infected Individuals

P. Goepfert, A. Dwivedi, A. Bansal, 2014, PloS one.

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

Lindsay N. Carpp, Mathieu Le Gars, M. Andrasik, 2022, medRxiv.

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.

David C Montefiori, Georgia D Tomaras, Avishek Nandi, 2010, Virology.

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

G. Pantaleo, M. McElrath, P. Gilbert, 2021, NPJ vaccines.

Identification of an ER retrieval signal in a retroviral glycoprotein

P. Goepfert, G. Wang, M. J. Mulligan, 1995, Cell.

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

I. Frank, P. Goepfert, S. Gurunathan, 2021, The Lancet Infectious Diseases.

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

D. Montefiori, S. Buchbinder, N. Frahm, 2017, PloS one.

Human Immunodeficiency Virus-Specific CD 8 T Cells in Human Breast Milk

M. Mulligan, G. Aldrovandi, P. Goepfert, 2002 .

Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection

O. Kutsch, P. Goepfert, A. Bansal, 2020, medRxiv.

Making sense of the HIV immune response.

P. Goepfert, 2003, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.

J. Kublin, A. Falsey, D. Follmann, 2023, JAMA network open.

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

A. Falsey, D. Montefiori, S. Little, 2023, medRxiv.

A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans.

Christopher D. Scharer, P. Goepfert, T. Randall, 2023, Immunity.

Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodies.

P. Goepfert, K. Honjo, E. Tabengwa, 2022, Protein engineering, design & selection : PEDS.

Fcrl5 and T-bet define influenza-specific memory B cells that predict long-lived antibody responses

J. Kearney, Christopher D. Scharer, P. Goepfert, 2019 .

Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region

P. Goepfert, S. Karuna, Maurine D. Miner, 2023, Journal of global health.

Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients

A. Westfall, P. Goepfert, A. Bansal, 2014, AIDS.

Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation.

P. Goepfert, R. K. Reeves, Haiying Li, 2014, AIDS research and human retroviruses.

Short Communication: Apoptotic Membrane Microparticles Quantified by Fluorescent Bead-Based Assay Are Elevated in HIV and SIV Infections.

P. Goepfert, R. K. Reeves, Haiying Li, 2018, AIDS research and human retroviruses.

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

J. Kublin, D. Montefiori, H. Schuitemaker, 2022, The Journal of infectious diseases.

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

A. Falsey, D. Montefiori, S. Little, 2023, Research square.

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.

M. McElrath, P. Goepfert, G. Ferrari, 2001, Immunology letters.

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

T. Ketas, B. Hahn, P. Goepfert, 2023, PLoS medicine.

Analysis of west African hunters for foamy virus infections.

M. Mulligan, P. Goepfert, A. Gbakima, 1996, AIDS research and human retroviruses.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Lindsay N. Carpp, Mathieu Le Gars, Ilse C. L. Van Dromme, 2023, Research square.

The tetraspanin CD151 is an activation molecule that characterizes M. tuberculosis- specific effector CD4+ T cells

O. Kutsch, P. Goepfert, L. Seu, 2016, Journal of Immunology.

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

J. Kublin, A. Falsey, D. Follmann, 2023, JAMA network open.

Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs

M. Betts, S. Kent, P. Goepfert, 2015, Front. Immunol..

Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials

J. Kublin, A. Falsey, D. Follmann, 2023, Vaccine.

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.

A. Falsey, D. Montefiori, S. Little, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41

H. Liao, Laura L. Sutherland, B. Haynes, 2011, PloS one.

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

K. Schmader, E. Walsh, A. Falsey, 2023, Nature Medicine.

D. Montefiori, S. Buchbinder, N. Frahm, 2017, PloS one.

Functionally competent antigen-specific CD127(hi) memory CD8+ T cells are preserved only in HIV-infected individuals receiving early treatment.

P. Goepfert, A. Bansal, J. Kilby, 2007, The Journal of infectious diseases.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

P. Goepfert, D. Strayer, E. Overton, 2014, Vaccine.

Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations.

E. Karita, P. Goepfert, S. Allen, 2017, Human immunology.

Risk of COVID-19 after natural infection or vaccination

Nicole L. Nollen, Eric A. Meyerowitz, Waseem M. Chughtai, 2023, EBioMedicine.